Here are three things to know.
1. If approved, the bill would give devicemakers 90 days, instead of 30, to report product malfunctions to the FDA. The legislation would also permit companies to summarize previous product malfunction reports, rather than filing detailed reports for each case.
2. The bill’s advocates say it will eliminate the repetitive process for reporting known product malfunctions, while critics believe the policy change could cause underreporting of malfunctions, which the FDA admits is already an issue.
3. The legislation would maintain a 30-day reporting period for device issues that directly cause patient injury.
More articles on supply chain:
7 must-reads for supply chain leaders this week
House passes FDA user fee reauthorization bill
Are outcomes-based drug contracts effective? 5 thoughts
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
